Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?

Area of Science:

• Endocrinology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Diabetes mellitus is a global metabolic disorder caused by pancreatic beta cell loss or dysfunction.
• Beta cell replacement via transplantation is a potential cure, but donor scarcity is a major limitation.
• Human pluripotent stem cells (hPSCs) offer a renewable source for generating beta cells for transplantation.

Purpose of the Study:

• To review current stem cell differentiation protocols for generating beta cells.
• To highlight challenges in achieving fully mature stem cell-derived beta cells.
• To discuss the clinical applicability and ongoing trials of stem cell-derived beta cells for diabetes.

Main Methods:

• Review of current literature on stem cell differentiation protocols for beta cell generation.
• Analysis of challenges in achieving functional maturity in stem cell-derived beta cells.
• Examination of opportunities presented by monogenic diabetes and clinical trial data.

Main Results:

• Significant progress has been made in generating stem cell-derived beta-like cells.
• Key challenges persist in achieving full functional maturity and long-term efficacy.
• Monogenic diabetes offers insights into specific differentiation pathways and therapeutic targets.

Conclusions:

• Stem cell-derived beta cells hold great promise for diabetes therapy, but maturity remains a hurdle.
• Further research is needed to overcome remaining challenges for widespread clinical application.
• Ongoing clinical trials are evaluating the safety and efficacy of these cell-based therapies.